SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-05-001778
Filing Date
2005-01-28
Accepted
2005-01-28 12:12:59
Documents
11
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 20-F a2150108z20-f.htm 20-F 2768931
2 EX-1.1 a2150108zex-1_1.htm EX-1.1 66359
3 EX-2.2 a2150108zex-2_2.htm EX-2.2 6669
4 EX-12.1 a2150108zex-12_1.htm EX-12.1 5994
5 EX-12.2 a2150108zex-12_2.htm EX-12.2 5980
6 EX-13 a2150108zex-13.htm EX-13 4357
7 EX-14.1 a2150108zex-14_1.htm EX-14.1 2497
8 G903347.JPG g903347.jpg GRAPHIC 8371
9 G77385.JPG g77385.jpg GRAPHIC 3464
10 G420130.JPG g420130.jpg GRAPHIC 1291
11 G902693.JPG g902693.jpg GRAPHIC 4659
  Complete submission text file 0001047469-05-001778.txt   2881115
Mailing Address LICHSTRASSE 35 BASEL SWITZERLAND CH 4056
Business Address LICHSTRASSE 35 BASEL SWITZERLAND V8 CH 4056
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-15024 | Film No.: 05556835
SIC: 2834 Pharmaceutical Preparations